Participants in Medigen Phase 3 clinical trials receive first shot

Taiwan-based Medigen Vaccine Biologics Corp. said Thursday that all 1,030 participants in its Phase 3 clinical trial in Paraguay have received their first vaccine shot of either the Medigen or AstraZeneca COVID-19 vaccines.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)